학술논문

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Document Type
Article
Author
Munro, Alasdair P SBartholomew, JazzPresland, LauraHorswill, SarahWarren, SarahVarkonyi-Clifford, SophieSaich, StephenAdams, KirstyRicamara, MarivicTurner, NicolaYee Ting, Nicole YWhittley, SarahRampling, TommyDesai, AmishaBrown, Claire HQureshi, EhsaanGokani, KarishmaNaker, KushKellett Wright, Johanna KWilliams, Rachel LRiaz, TawassalPenciu, Florentina DDi Maso, ClaudioHowe, Elizabeth GVichos, IasonGhulam Farooq, MujtabaNoristani, RabiullahYao, Xin LOldfield, Neil JHammersley, DanielBelton, SueRoyal, SimonSan Francisco Ramos, AlbertoHultin, CeciliaGaliza, Eva PShiham, FarahSolórzano, CarlaSainsbury, HannahDavies, KellyAmbrose, PaulineHitchins, LisaBaker, NatalieLeung, StephanieFothergill, RossGodwin, KerryButtigieg, KarenShaik, ImamBrown, PhillKnight, ChaniceLall, PaminderAllen, LaurenLiu, XinxueShaw, Robert HStuart, Arabella S VGreenland, MelanieAley, Parvinder KAndrews, Nick JCameron, J ClaireCharlton, SueClutterbuck, Elizabeth ACollins, Andrea MDinesh, TanyaEngland, AnnaFaust, Saul NFerreira, Daniela MFinn, AdamGreen, Christopher AHallis, BassamHeath, Paul THill, HelenLambe, TeresaLazarus, RajekaLibri, VincenzoLong, FeiMujadidi, Yama FPlested, Emma LProvstgaard-Morys, SamuelRamasamy, Maheshi NRamsay, MaryRead, Robert CRobinson, HannahSingh, NishaTurner, David P JTurner, Paul JWalker, Laura LWhite, RachelNguyen-Van-Tam, Jonathan SSnape, Matthew D
Source
In The Lancet 4-10 September 2021 398(10303):856-869
Subject
Primary Research
Articles
Language
ISSN
0140-6736